116 related articles for article (PubMed ID: 18823279)
1. WITHDRAWN:Curcumin, a dietary polyphenol, emerges as a novel inhibitor of DNA topoisomerase I of kinetoplastid parasite Leishmania donovani.
Das R; Roy A; Ganguly A; Datta N; Majumder HK
Biochem J; 2008 Sep; ():. PubMed ID: 18823279
[TBL] [Abstract][Full Text] [Related]
2. A tyrosyl DNA phosphodiesterase 1 from kinetoplastid parasite Leishmania donovani (LdTdp1) capable of removing topo I-DNA covalent complexes.
Banerjee B; Roy A; Sen N; Majumder HK
Mol Microbiol; 2010 Oct; 78(1):119-37. PubMed ID: 20659295
[TBL] [Abstract][Full Text] [Related]
3. An insight into the active site of a type I DNA topoisomerase from the kinetoplastid protozoan Leishmania donovani.
Das A; Mandal C; Dasgupta A; Sengupta T; Majumder HK
Nucleic Acids Res; 2002 Feb; 30(3):794-802. PubMed ID: 11809893
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Functional Type IA Topoisomerase, LdTopIIIβ, from Kinetoplastid Parasite Leishmania donovani.
Banerjee B; Sen N; Majumder HK
Enzyme Res; 2011; 2011():230542. PubMed ID: 21637326
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of the gene encoding type II DNA topoisomerase from Leishmania donovani: a key molecular target in antileishmanial therapy.
Das A; Dasgupta A; Sharma S; Ghosh M; Sengupta T; Bandopadhyay S; Majumder HK
Nucleic Acids Res; 2001 May; 29(9):1844-51. PubMed ID: 11328867
[TBL] [Abstract][Full Text] [Related]
6. Diospyrin, a bisnaphthoquinone: a novel inhibitor of type I DNA topoisomerase of Leishmania donovani.
Ray S; Hazra B; Mittra B; Das A; Majumder HK
Mol Pharmacol; 1998 Dec; 54(6):994-9. PubMed ID: 9855627
[TBL] [Abstract][Full Text] [Related]
7. Differential induction of Leishmania donovani bi-subunit topoisomerase I-DNA cleavage complex by selected flavones and camptothecin: activity of flavones against camptothecin-resistant topoisomerase I.
Das BB; Sen N; Roy A; Dasgupta SB; Ganguly A; Mohanta BC; Dinda B; Majumder HK
Nucleic Acids Res; 2006; 34(4):1121-32. PubMed ID: 16488884
[TBL] [Abstract][Full Text] [Related]
8. Isobenzofuranone derivative JVPH3, an inhibitor of L. donovani topoisomerase II, disrupts mitochondrial architecture in trypanosomatid parasites.
Chowdhury SR; Godinho JLP; Vinayagam J; Zuma AA; Silva STM; Jaisankar P; Rodrigues JCF; De Souza W; Majumder HK
Sci Rep; 2018 Aug; 8(1):11940. PubMed ID: 30093616
[TBL] [Abstract][Full Text] [Related]
9. The lignan glycosides lyoniside and saracoside poison the unusual type IB topoisomerase of Leishmania donovani and kill the parasite both in vitro and in vivo.
Saha S; Mukherjee T; Chowdhury S; Mishra A; Chowdhury SR; Jaisankar P; Mukhopadhyay S; Majumder HK
Biochem Pharmacol; 2013 Dec; 86(12):1673-87. PubMed ID: 24134912
[TBL] [Abstract][Full Text] [Related]
10. Topoisomerases of kinetoplastid parasites: why so fascinating?
Das BB; Sengupta T; Ganguly A; Majumder HK
Mol Microbiol; 2006 Nov; 62(4):917-27. PubMed ID: 17042788
[TBL] [Abstract][Full Text] [Related]
11. Editorial Expression of Concern on article 'Functional dissection of the C-terminal domain of type II DNA topoisomerase from the kinetoplastid hemoflagellate Leishmania donovani'.
Nucleic Acids Res; 2021 Apr; 49(6):3601. PubMed ID: 33693849
[No Abstract] [Full Text] [Related]
12. Voacamine alters Leishmania ultrastructure and kills parasite by poisoning unusual bi-subunit topoisomerase IB.
Chowdhury SR; Kumar A; Godinho JLP; De Macedo Silva ST; Zuma AA; Saha S; Kumari N; Rodrigues JCF; Sundar S; Dujardin JC; Roy S; De Souza W; Mukhopadhyay S; Majumder HK
Biochem Pharmacol; 2017 Aug; 138():19-30. PubMed ID: 28483460
[TBL] [Abstract][Full Text] [Related]
13. Functional dissection of the C-terminal domain of type II DNA topoisomerase from the kinetoplastid hemoflagellate Leishmania donovani.
Sengupta T; Mukherjee M; Mandal C; Das A; Majumder HK
Nucleic Acids Res; 2003 Sep; 31(18):5305-16. PubMed ID: 12954766
[TBL] [Abstract][Full Text] [Related]
14. Computational evaluation of phytochemicals targeting DNA topoisomerase I in
Arya PK; Mandal P; Barik K; Singh DV; Kumar A
J Biomol Struct Dyn; 2023 Sep; ():1-14. PubMed ID: 37697722
[TBL] [Abstract][Full Text] [Related]
15. Topoisomerase research of kinetoplastid parasite Leishmania, with special reference to development of therapeutics.
Das BB; Sen N; Dasgupta SB; Ganguly A; Das R; Majumder HK
Indian J Med Res; 2006 Mar; 123(3):221-32. PubMed ID: 16778306
[TBL] [Abstract][Full Text] [Related]
16. A novel active DNA topoisomerase I in Leishmania donovani.
Villa H; Otero Marcos AR; Reguera RM; Balaña-Fouce R; García-Estrada C; Pérez-Pertejo Y; Tekwani BL; Myler PJ; Stuart KD; Bjornsti MA; Ordóñez D
J Biol Chem; 2003 Feb; 278(6):3521-6. PubMed ID: 12444094
[TBL] [Abstract][Full Text] [Related]
17. Leishmania donovani bisubunit topoisomerase I gene fusion leads to an active enzyme with conserved type IB enzyme function.
Das BB; Bose Dasgupta S; Ganguly A; Mazumder S; Roy A; Majumder HK
FEBS J; 2007 Jan; 274(1):150-63. PubMed ID: 17222179
[TBL] [Abstract][Full Text] [Related]
18. An insight into the mechanism of inhibition of unusual bi-subunit topoisomerase I from Leishmania donovani by 3,3'-di-indolylmethane, a novel DNA topoisomerase I poison with a strong binding affinity to the enzyme.
Roy A; Das BB; Ganguly A; Bose Dasgupta S; Khalkho NV; Pal C; Dey S; Giri VS; Jaisankar P; Dey S; Majumder HK
Biochem J; 2008 Jan; 409(2):611-22. PubMed ID: 17922678
[TBL] [Abstract][Full Text] [Related]
19. A bioinformatics approach to reanalyze the genome annotation of kinetoplastid protozoan parasite Leishmania donovani.
Pawar H; Kulkarni A; Dixit T; Chaphekar D; Patole MS
Genomics; 2014 Dec; 104(6 Pt B):554-61. PubMed ID: 25265881
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Leishmania donovani promastigote DNA topoisomerase I and human monocyte DNA topoisomerases I and II by antimonial drugs and classical antitopoisomerase agents.
Walker J; Saravia NG
J Parasitol; 2004 Oct; 90(5):1155-62. PubMed ID: 15562618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
